Provider
Also: Zipari rounds out its C-suite with two appointments.
Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.
The funds will be used to accelerate HMNC’s pipeline development towards market maturity.
AI algorithms will inform treatment decisions by recognising patterns of data from past treatments.
The combined platform enables self-service information around schedules, visit details, requests, care notes, statements and budget use.
Hearoes is a mobile platform that trains people experiencing hearing loss with gamified and engaging activities to identify new sounds.
This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010.
The new system can be used with Apple iPhones and lets users check their glucose without needing a reader.
WellSky will add Healthify’s SDOH capabilities to its portfolio of healthcare technology tools for providers, payers, health systems and community organizations.
Funded in part by the European Regional Development Fund, the initiative aims to support digital innovations being used by the NHS in London.